LAZARD ASSET MANAGEMENT LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$41
-30.5%
9,8940.0%0.00%–
Q4 2022$59
-99.9%
9,8940.0%0.00%–
Q3 2022$57,000–9,894–0.00%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders